Akers Biosciences Inc – IPO: ‘S-1’ on 8/7/13 – EX-3.4

On:  Wednesday, 8/7/13, at 5:16pm ET   ·   Accession #:  1144204-13-43672   ·   File #:  333-190456

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML    845K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML      9K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML      7K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     39K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML      7K 
 6: EX-3.5      Articles of Incorporation/Organization or By-Laws   HTML     57K 
 7: EX-10.1     Material Contract                                   HTML     61K 
 8: EX-10.2     Material Contract                                   HTML     56K 
 9: EX-10.3     Material Contract                                   HTML     51K 
10: EX-10.4     Material Contract                                   HTML     43K 
11: EX-10.5     Material Contract                                   HTML     59K 
12: EX-10.6     Material Contract                                   HTML     55K 
13: EX-10.7     Material Contract                                   HTML    166K 
14: EX-10.8     Material Contract                                   HTML    138K 
15: EX-10.9     Material Contract                                   HTML     26K 
16: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
17: EX-99.1     Miscellaneous Exhibit                               HTML      9K 

EX-3.4   —   Articles of Incorporation/Organization or By-Laws

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/23  MyMD Pharmaceuticals, Inc.        424B5                  1:459K                                   M2 Compliance LLC/FA
 8/17/22  MyMD Pharmaceuticals, Inc.        424B5                  1:406K                                   M2 Compliance LLC/FA
 3/31/22  MyMD Pharmaceuticals, Inc.        10-K       12/31/21   77:11M                                    M2 Compliance LLC/FA
 5/11/21  MyMD Pharmaceuticals, Inc.        424B3                  1:392K                                   M2 Compliance LLC/FA
 4/28/21  MyMD Pharmaceuticals, Inc.        S-3/A                  5:840K                                   M2 Compliance LLC/FA
 3/25/21  MyMD Pharmaceuticals, Inc.        S-3                    5:793K                                   M2 Compliance LLC/FA
 3/19/21  MyMD Pharmaceuticals, Inc.        S-4/A                121:17M                                    M2 Compliance LLC/FA
 3/01/21  MyMD Pharmaceuticals, Inc.        10-K       12/31/20   69:7.8M                                   M2 Compliance LLC/FA
 1/15/21  MyMD Pharmaceuticals, Inc.        S-4                    6:9.5M                                   M2 Compliance LLC/FA
11/16/20  MyMD Pharmaceuticals, Inc.        10-Q        9/30/20   57:6.6M                                   M2 Compliance LLC/FA
10/21/20  MyMD Pharmaceuticals, Inc.        10-K/A     12/31/19    6:1.1M                                   M2 Compliance LLC/FA
 8/14/20  MyMD Pharmaceuticals, Inc.        10-Q        6/30/20   59:6M                                     M2 Compliance LLC/FA
11/26/13  SEC                               UPLOAD¶     9/27/17    1:159K MyMD Pharmaceuticals, Inc.
11/14/13  SEC                               UPLOAD¶     9/27/17    1:158K MyMD Pharmaceuticals, Inc.
10/25/13  SEC                               UPLOAD¶     9/27/17    1:167K MyMD Pharmaceuticals, Inc.
 9/04/13  SEC                               UPLOAD¶     9/27/17    1:245K MyMD Pharmaceuticals, Inc.